Related Experiment Video
Updated: Aug 6, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
A Rare Case of Recurrent Immunotactoid Glomerulonephritis
Mohankumar Doraiswamy1,2, Samir V Parikh3, Sergey Brodsky4
1Department of Internal Medicine, Arkansas College of Osteopathic Medicine, Fort Smith, USA.
Immunotactoid glomerulopathy is a rare kidney disease caused by immunoglobulin deposits. This case study shows successful treatment of recurrent immunotactoid glomerulonephritis with rituximab.
Area of Science:
- Nephrology
- Immunopathology
Background:
- Immunotactoid glomerulopathy (ITG) is a rare glomerular disease characterized by immunoglobulin deposits.
- It affects both native and transplant kidneys, accounting for 0.5% to 1.4% of native kidney biopsies.
- Treatment focuses on underlying conditions like monoclonal gammopathies and B-cell disorders.
Observation:
- Presents a rare case of recurrent immunotactoid glomerulonephritis.
- The patient's condition involved the native kidney.
Findings:
- The recurrent immunotactoid glomerulonephritis demonstrated an appropriate response to rituximab therapy.
- This suggests rituximab as a potential treatment option for this rare condition.
Implications:
- Rituximab therapy may offer a viable treatment strategy for recurrent immunotactoid glomerulonephritis.
- Further research into B-cell targeted therapies for ITG is warranted.
- Improved understanding of ITG pathogenesis could lead to better prognostic markers and therapeutic targets.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Kidney Transplant II: Surgical Procedure
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury III: Clinical Manifestations
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management

